BioNova Pharma Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 9

BioNova Pharma General Information

Description

Manufacturer of innovative drugs designed to advance clinical treatment for cancer and life-threatening diseases. The company offers a robust pipeline built on proprietary R&D, international collaborations, and advanced biotechnologies, enabling patients in China and worldwide to access novel medicines.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 901, Building B, Changtai Plaza, Lane 2889
  • Jinke Road, Pudong New Area
  • Shanghai, 201203
  • China
+86 021
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Room 901, Building B, Changtai Plaza, Lane 2889
  • Jinke Road, Pudong New Area
  • Shanghai, 201203
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioNova Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private Completed Generating Revenue
3. Early Stage VC (Series B1) 23-Nov-2020 Completed Generating Revenue
2. Early Stage VC (Series B) 17-Aug-2020 Completed Generating Revenue
1. Early Stage VC (Series A) 25-Dec-2018 Completed Startup
To view BioNova Pharma’s complete valuation and funding history, request access »

BioNova Pharma Patents

BioNova Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025180390-A1 Mta-cooperative prmt5 inhibitor compound having tetracyclic fused-ring structure Pending 27-Feb-2024
CA-3239857-A1 Carbonyl substituted diazaspiro compounds and its use Pending 03-Dec-2021
US-20240317748-A1 Carbonyl substituted diazaspiro compounds and its use Active 03-Dec-2021
WO-2023098876-A1 Carbonyl substituted diazaspiro compounds and its use Inactive 03-Dec-2021
WO-2022228302-A1 Heteroaromatic carboxamide compounds and its use Inactive 25-Apr-2021 A61K45/06
To view BioNova Pharma’s complete patent history, request access »

BioNova Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioNova Pharma Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
GP Capital (Shanghai) PE/Buyout Minority
Hanne Capital Growth/Expansion Minority
Rencent Capital Venture Capital Minority
BioTrack Capital Venture Capital Minority
LAV (Lilly Asia Fund) Corporate Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

BioNova Pharma Investments (1)

BioNova Pharma’s most recent deal was a Joint Venture with BK Pharmaceuticals. The deal was made on 07-Nov-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
BK Pharmaceuticals 07-Nov-2019 Joint Venture Pharmaceuticals
To view BioNova Pharma’s complete investments history, request access »

BioNova Pharma FAQs

  • When was BioNova Pharma founded?

    BioNova Pharma was founded in 2018.

  • Where is BioNova Pharma headquartered?

    BioNova Pharma is headquartered in Shanghai, China.

  • What is the size of BioNova Pharma?

    BioNova Pharma has 4 total employees.

  • What industry is BioNova Pharma in?

    BioNova Pharma’s primary industry is Drug Discovery.

  • Is BioNova Pharma a private or public company?

    BioNova Pharma is a Private company.

  • What is BioNova Pharma’s current revenue?

    The current revenue for BioNova Pharma is .

  • Who are BioNova Pharma’s investors?

    GP Capital (Shanghai), Hanne Capital, Rencent Capital, BioTrack Capital, and LAV (Lilly Asia Fund) are 5 of 9 investors who have invested in BioNova Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process